PDF herunterladen
Synlett 2007(10): 1537-1540  
DOI: 10.1055/s-2007-982539
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthetic Studies on a Marine Natural Product, Palmerolide A: Synthesis of C1-C9 and C15-C21 Fragments

Krishna P. Kaliappan*, Parthasarathy Gowrisankar
Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India
Fax: +91(22)5723480; e-Mail: kpk@chem.iitb.ac.in;
Weitere Informationen

Publikationsverlauf

Received 13 March 2007
Publikationsdatum:
06. Juni 2007 (online)

   Lizenzen und Reprints Alle Artikel dieser Rubrik
Preview

Abstract

An efficient cross metathesis and Pd-catalyzed allylic rearrangement have been successfully used to construct the northern hemisphere of a cytotoxic marine natural product, palmerolide A.

Key words

Grubbs’ catalyst - cross metathesis - Pd(II)-catalyzed ­allylic rearrangement - marine natural product - Mitsunobu reaction

    References and Notes

  • 1 Diyabalange T. Amsler CD. McClintock JB. Baker BJ. J. Am. Chem. Soc.  2006,  128:  5630 
    Suche in Google Scholar
  • 2a White JD. Kawasaki M. J. Org. Chem.  1992,  57:  5292 
    Suche in Google Scholar
  • 2b Roush WR. Palkowitz AD. Ando K. J. Am. Chem. Soc.  1990,  112:  6348 
    Suche in Google Scholar
  • 3a Harried SS. Lee CP. Yang G. Lee TIH. Myles DC. J. Org. Chem.  2003,  68:  6646 
    Suche in Google Scholar
  • 3b White JD. Blakemore PR. Green NJ. Hauser EB. Holoboski MA. Keown LE. Kolz CSN. Phillips BW. J. Org. Chem.  2002,  67:  7750 
    Suche in Google Scholar
  • 3c Keck GE. Abbott DE. Tetrahedron Lett.  1984,  25:  1883 
    Suche in Google Scholar
  • 4 Smith AB. Cho YS. Friestad GK. Tetrahedron Lett.  1998,  39:  8765 
    Suche in Google Scholar
  • 5 Overman LE. Knoll FM. Tetrahedron Lett.  1979,  20:  321 
    Suche in Google Scholar
  • 6 Nakajima N. Horita K. Abe R. Yonemitsu O. Tetrahedron Lett.  1988,  29:  4139 
    Suche in Google Scholar
  • 8 Ho G.-J. Mathre DJ. J. Org. Chem.  1995,  60:  2271 
    Suche in Google Scholar
  • 9 Evans DA. Morrissey MM. Dorow RL. J. Am. Chem. Soc.  1985,  107:  4346 
    Suche in Google Scholar
  • 10a Vishwakarma LC. Stringer OD. Davis FA. Org. Synth., Coll. Vol. VIII  1993,  546 
  • 10b Davis FA. Stringer OD. J. Org. Chem.  1982,  47:  1774 
    Suche in Google Scholar
  • 11 Prashad M. Har D. Kim H.-Y. Repic O. Tetrahedron Lett.  1998,  39:  7067 
    Suche in Google Scholar
  • 12 Takano S. Akiyama M. Sato S. Ogasawara K. Chem. Lett.  1983,  1593 
  • 13 Chatterjee AK. Grubbs RH. Angew. Chem. Int. Ed.  2002,  41:  3171 
    Suche in Google Scholar
  • 14 Dess DB. Martin JC. J. Org. Chem.  1983,  48:  4155 
    Suche in Google Scholar
  • 15 Kireev AS. Breithaupt AT. Collins W. Nadein ON. Kornienko A. J. Org. Chem.  2005,  70:  742 
    Suche in Google Scholar
  • 16a Conia JM. Limasset JC. Bull. Soc. Chim. Fr.  1967,  1936 
  • 16b Fitjer L. Quabeck U. Synth. Commun.  1985,  15:  855 
    Suche in Google Scholar
7

Experimental Procedure for Compound 18 To a solution of acetate 17 (230 mg, 0.54 mmol) in anhyd THF (10 mL) was added PdCl2(MeCN)2 (6 mg, 4 mol%) at 0 °C under nitrogen. After being stirred at 0 °C for 30 min, the mixture was further stirred at r.t. for another 1 h. The solvent was evaporated and the residue was further purified by flash chromatography (silica gel, 5-10% EtOAc-hexanes) to afford the E/Z mixture of acetate (200 mg, 0.47 mmol, 87%). To a solution of the above acetate (160 mg, 0.37 mmol) in CH2Cl2 (3.4 mL) and buffer (pH 7, 390 µL) was added DDQ (102 mg, 0.45 mmol) at 0 °C. After being stirred at the same temperature for 1 h, the reaction mixture was quenched with sat. NaHCO3 (8 mL) and the aqueous layer was extracted with CH2Cl2 (4 × 10 mL). The combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by flash column chromatography (silica gel, 10-20% EtOAc-hexanes) to give the Z-isomer 19, (8 mg, 0.026 mmol, 7%) as a colorless oil and the E-isomer 18 (80 mg, 0.26 mmol, 70%) as a pale yellow oil in a ratio of 1:10.
Data for compound 18: R f = 0.8 (20% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 7.37-7.27 (m, 5 H), 5.43 (tq, J = 7.0, 1.2 Hz, 1 H), 4.60 (d, J = 7.0 Hz, 2 H), 4.51 (s, 2 H), 3.95 (m, 1 H), 3.53 (d, J = 0.6 Hz, 1 H), 3.52 (s, 1 H), 2.47 (br s, 1 H), 2.23-2.06 (m, 2 H), 2.05 (s, 3 H), 1.89-1.84 (m, 1 H), 1.75 (d, J = 1.2 Hz, 3 H), 0.96 (d, J = 7.0 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 171.0, 139.3, 137.9, 128.3, 127.6, 127.5, 121.1, 74.4, 73.3, 70.9, 61.1, 44.2, 37.6, 20.9, 16.5, 10.7. IR (neat): 3477 (br), 2966, 2931, 2868, 1733, 1450, 1373, 1239, 1098, 1027, 743 cm-1. HRMS (ESI-TOF): m/z calcd for [C18H26O4 + Na]+: 329.1729; found: 329.1723. [α]D 20 4.3 (c 1.45, CHCl3).

17

Procedure for the Synthesis of Compound 28 A solution of methyltriphenylphosphonium bromide (273 mg, 0.76 mmol) in dry toluene (12 mL) was heated to reflux and about 10 mL of toluene were distilled off azeotropically to remove moisture. To the above suspension was added KOt-Bu (86 mg, 0.76 mmol), the mixture was stirred at 105 °C for 1 h, and then cooled to 0 °C. A solution of aldehyde (180 mg, 0.58 mmol) in dry toluene (0.5 mL) was added dropwise to the above suspension with stirring, and the resulting mixture was stirred at 0 °C for 1 h. After addition of sat. NH4Cl (5 mL), the resulting mixture was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. The resulting residue was purified by flash column chromatography (silica gel, 5-15% EtOAc-hexanes) to give 28 (116 mg, 0.38 mmol, 65% for two steps) as a colorless oil. R f = 0.57 (30% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 7.25 (dt, J = 8.9, 2.1 Hz, 2 H), 6.94 (dt, J = 15.6, 7.0 Hz, 1 H), 6.87 (dt, J = 8.9, 2.2 Hz, 2 H), 5.79 (dt, J = 15.5, 1.5 Hz, 1 H), 5.71 (ddd, J = 17.1, 10.4, 7.9 Hz, 1 H), 5.26-5.18 (m, 2 H), 4.39 (AB pattern, J = 11.6 Hz, 2 H), 3.80 (s, 3 H), 3.72 (s, 3 H), 3.77-3.67 (m, 1 H), 2.19-2.14 (m, 2 H), 1.64-1.46 (m, 4 H). 13C NMR (100 MHz, CDCl3): δ = 167.0, 159.0, 149.2, 138.8, 130.6, 129.3, 120.9, 117.2, 113.7, 79.6, 69.6, 55.1, 51.3, 34.8, 31.9, 23.8. IR (neat): 2948, 2838, 1724, 1657, 1613, 1514, 1463, 1248, 1201, 1172, 1036, 928 cm-1. HRMS (ESI-TOF): m/z calcd for [C18H24O4 + Na]+: 327.1572; found: 327.1588. [α]D 20 34.3 (c 2.15, CHCl3).

18

Spectral Data for Selected Compounds
Data for ketone 11: R f = 0.34 (30% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 8.24 (dt, J = 8.8, 2.1 Hz, 2 H), 8.12 (dt, J = 9.2, 2.2 Hz, 2 H), 7.29-7.23 (m, 5 H), 5.72 (dt, J = 7.7, 5.1 Hz, 1 H), 4.46 (s, 2 H), 3.42 (d, J = 6.2 Hz, 2 H), 2.93 (dd, J = 16.5, 7.7 Hz, 1 H), 2.82 (dd, J = 16.5, 5.5 Hz, 1 H), 2.26-2.19 (m, 1 H), 2.17 (s, 3 H), 1.06 (d, J = 7.0 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 205.1, 163.9, 150.4, 138.0, 135.6, 130.6, 128.2, 127.6, 127.5, 123.4, 73.1, 72.7, 71.9, 45.7, 37.1, 30.1, 12.1. IR (neat): 2933, 2863, 1725, 1607, 1528, 1411, 1349, 1275, 1169, 1102 cm-1. HRMS (ESI-TOF): m/z calcd for [C21H23O6N + Na]+: 408.1423; found: 408.1422. [α]D 20 -10.7 (c 0.67, CHCl3).
Data for compound 12: R f = 0.35 (20% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 7.37-7.27 (m, 5 H), 6.79 (dd, J = 16.2, 7.0 Hz, 1 H), 6.11 (dd, J = 16.2, 1.5 Hz, 1 H), 4.52 (s, 2 H), 3.42 (d, J = 6.7 Hz, 2 H), 2.72-2.65 (m, 1 H), 2.25 (s, 3 H), 1.10 (d, J = 6.7 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 198.7, 150.2, 138.1, 130.6, 128.4, 127.6, 127.5, 73.9, 73.1, 36.9, 26.8, 16.0. IR (neat): 2965, 2856, 1676, 1626, 1528, 1454, 1360, 1257, 1099, 982, 739, 699 cm-1. HRMS (ESI-TOF): m/z calcd for [C14H18O2 + Na]+: 241.1204; found: 241.1214. [α]D 20 -15.8 (c 1.13, CHCl3).
Data for compound 16: R f = 0.28 (10% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 7.36-7.27 (m, 5 H), 7.19 (dt, J = 8.8, 2.1 Hz, 2 H), 6.84 (dt, J = 8.8, 2.1 Hz, 2 H), 4.46 (d, J = 1.5 Hz, 2 H), 4.43 (d, J = 7.3 Hz, 2 H), 4.08 (dt, J = 7.9, 4.3 Hz, 1 H), 3.78 (s, 3 H), 3.49 (dd, J = 8.8, 6.7 Hz, 1 H), 3.33 (dd, J = 9.2, 6.1 Hz, 1 H), 2.74 (dd, J = 16.2, 8.2 Hz, 1 H), 2.52 (dd, J = 16.2, 4.6 Hz, 1 H), 2.13 (s, 3 H), 2.04-1.99 (m, 1 H), 0.96 (d, J = 7.0 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 207.8, 159.1, 138.5, 130.8, 129.5, 129.4, 128.4, 127.7, 127.6, 113.7, 76.0, 73.0, 72.3, 55.3, 46.5, 37.5, 31.1, 12.4. IR (neat): 2917, 2861, 1715, 1611, 1513, 1457, 1361, 1301, 1248, 1173, 1078, 822 cm-1. HRMS (ESI-TOF): m/z calcd for [C22H28O4 + Na]+: 379.1885; found: 379.1880. [α]D 20 9.7 (c 1.05, CHCl3). Data for compound 30: R f = 0.55 (25% EtOAc-hexanes). 1H NMR (400 MHz, CDCl3): δ = 7.34-7.26 (m, 7 H), 6.92-6.84 (m, 3 H), 5.74 (d, J = 15.9 Hz, 1 H), 5.74-5.67 (m, 1 H), 5.37-5.19 (m, 4 H), 4.57-4.43 (m, 5 H), 4.27 (d, J = 11.3 Hz, 1 H), 3.8 (s, 3 H), 3.78-3.68 (m, 1 H), 3.38-3.27 (m, 2 H), 2.37-2.13 (m, 4 H), 2.03-1.96 (m, 1 H), 2.01 (s, 3 H), 1.74 (s, 3 H), 1.72-1.47 (m, 4 H), 0.97 (d, J = 6.7 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.9, 166.0, 159.0, 148.8, 138.9, 138.4, 138.3, 130.7, 129.3, 128.3, 127.6, 127.5, 121.6, 121.4, 117.2, 113.7, 79.8, 73.1, 72.5, 71.5, 69.7, 61.0, 55.2, 42.2, 36.8, 35.0, 32.0, 23.8, 20.9, 16.4, 11.4. IR (neat): 2961, 2930, 2851, 2361, 1738, 1715, 1513, 1454, 1260, 1245, 1091, 1027, 801 cm-1. HRMS (ESI-TOF): m/z calcd for [C35H46O7 + Na]+: 601.3141; found: 601.3146. [α]D 20 9.8 (c 0.60, CHCl3).